Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Inflammation and Oxidative Stress Markers and Esophageal Adenocarcinoma Incidence in a Barrett's Esophagus Cohort.
[esophageal adenocarcinoma]
Persons
with
Barrett
's
esophagus
experience
increased
risk
of
esophageal
adenocarcinoma
.
Prediagnostic
inflammation
markers
predict
several
cancers
,
but
their
role
in
predicting
esophageal
adenocarcinoma
is
unknown
.
We
investigated
whether
biomarkers
of
inflammation
[
C-
reactive
protein
(
CRP
)
,
interleukin-
6
(
IL
6
)
,
soluble
tumor
necrosis
factor
(
sTNF
)
receptors
I
and
II
]
,
and
of
oxidative
stress
(
F
2
-
isoprostanes
)
predicted
progression
to
esophageal
adenocarcinoma
in
a
prospective
cohort
of
397
patients
with
Barrett
's
esophagus
,
45
of
whom
developed
esophageal
adenocarcinoma
.
Biomarkers
were
measured
in
stored
plasma
samples
from
two
time
points
during
follow-up
,
the
mean
of
which
served
as
the
primary
predictor
.
Adjusted
hazard
ratios
(
HR
)
and
95
%
confidence
intervals
(
CI
)
were
estimated
using
Cox
regression
.
CRP
level
above
the
median
was
associated
with
an
80
%
increased
risk
of
esophageal
adenocarcinoma
.
The
HR
and
95
%
CI
adjusted
for
age
,
gender
,
and
further
adjusted
for
waist-
hip
ratio
and
smoking
were
1
.
98
(
1
.
05
-
3
.
73
)
and
1
.
77
(
0
.
93
-
3
.
37
)
,
respectively
,
with
Ptrend
for
continuous
CRP
=
0
.
04
.
Persons
with
IL
6
levels
above
the
median
also
had
almost
2
-
fold
increased
risk
[
HR
and
95
%
CI
adjusted
for
age
and
gender
,
and
further
adjusted
for
waist-
hip
ratio
and
smoking
were
1
.
95
(
1
.
03
-
3
.
72
)
and
1
.
79
(
0
.
93
-
3
.
43
)
,
respectively
,
but
no
evidence
of
a
trend
was
observed
]
.
Concentrations
of
TNF
receptors
and
F
2
-
isoprostanes
were
not
associated
with
esophageal
adenocarcinoma
risk
.
Further
research
is
needed
to
evaluate
the
role
of
inflammation
and
associated
markers
in
esophageal
adenocarcinoma
development
in
persons
with
Barrett
's
esophagus
.
This
prospective
study
suggests
that
inflammation
markers
,
particularly
CRP
and
IL
6
,
may
help
identify
persons
at
higher
risk
of
progression
to
esophageal
adenocarcinoma
.
Cancer
Epidemiol
Biomarkers
Prev
;
23
(
11
)
;
2393
-
403
.
©
2014
AACR
.
Diseases
Validation
Diseases presenting
"increased risk [hr and 95%"
symptom
esophageal adenocarcinoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom